JNJ

Johnson & Johnson, Merck lay off workers in China as local headwinds take a toll
Fierce Pharma
Wed, 11/20/24 - 08:41 pm
JNJ
Merck
China
layoffs
Prostate cancer: Three drug trials to watch
Clinical Trials Arena
Tue, 11/19/24 - 11:22 am
prostate cancer
clinical trials
Candel Therapeutics
ProstAtak
JNJ
Akeega
Pfizer
Mevrometostat
Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis
Clinical Trials Arena
Tue, 11/19/24 - 11:00 am
JNJ
clinical trials
JNJ-2113
psoriasis
J&J’s nipocalimab shows promise in Phase II Sjögren’s disease trial
Clinical Trials Arena
Fri, 11/15/24 - 11:02 am
JNJ
nipocalimab
Sjögren’s syndrome
Johnson & Johnson Takes the 340B Drug Rebate Fight to Federal Court
MedCity News
Wed, 11/13/24 - 09:48 pm
JNJ
340B
legal
drug rebates
J&J Brings Ottava into the Forefront of Surgical Robotics with New IDE Approval
Medical Devices and Diagnostics Industry
Tue, 11/12/24 - 08:41 pm
JNJ
Medtech
robotic surgery
Ottava
Spravato is just the beginning in a new wave of depression meds
Pharma Voice
Mon, 11/11/24 - 11:26 am
JNJ
Spravato
depression
drug development
J&J angles Darzalex for first move into early-stage myeloma with trial win, FDA filing
Fierce Pharma
Fri, 11/8/24 - 11:52 am
JNJ
Darzalex
Multiple Myeloma
FDA
J&J Joins Medtronic & Boston Sci in PFA Race with FDA Approval of Varipulse
Medical Devices and Diagnostics Industry
Fri, 11/8/24 - 12:03 am
Medtech
JNJ
Varipulse
FDA
atrial fibrillation
Medtronic
Boston Scientific
J&J’s Shockwave deal pays off as IVL catheter meets primary endpoint in trial
Clinical Trials Arena
Tue, 11/5/24 - 11:16 am
Medtech
JNJ
Shockwave Medical
IVL catheters
Javelin
peripheral artery disease
Pharmas ask appeals court to reconsider IRA lawsuits
Pharmaphorum
Mon, 11/4/24 - 11:08 am
Inflation Reduction Act
legal
drug pricing
JNJ
Bristol Myers Squibb
AstraZeneca
Big Pharma earnings hang hope on the next generation of blockbusters
Pharma Voice
Thu, 10/31/24 - 09:19 am
Pfizer
JNJ
Biogen
Novartis
earnings
Dueling IL-23 data drop as Lilly, J&J await FDA decisions in Crohn's
First Word Pharma
Mon, 10/28/24 - 06:24 pm
Eli Lilly
JNJ
Crohn's Disease
FDA
clinical trials
Tremfya
Omvoh
J&J Reports Positive Data in Impella ECP Trial
Medical Devices and Diagnostics Industry
Mon, 10/28/24 - 06:18 pm
Abiomed
JNJ
Johnson & Johnson MedTech
Imprella ECP
medtehc
Medtronic Earns Another PFA Approval, Is J&J Next in Line?
Medical Devices and Diagnostics Industry
Sun, 10/27/24 - 07:35 pm
Medtech
pulsed field ablation
Medtronic
Boston Scientific
JNJ
J&J, Eli Lilly pad immunology profiles with trial readouts in new patient groups
Fierce Pharma
Fri, 10/25/24 - 11:43 am
JNJ
Eli Lilly
Tremfya
immunology
plaque psoriasis
Ebglyss
atopic dermatits
J&J’s comeback kid Spravato heads for blockbuster status
Pharma Voice
Fri, 10/25/24 - 11:13 am
JNJ
esketamine
Spravato
Activist investor Starboard sets its sights on J&J spinout Kenvue
Fierce Pharma
Mon, 10/21/24 - 11:38 pm
Starboard
Pfizer
JNJ
Kenvue
activist investors
Tremfya, Carvykti sales grow as J&J prepares for Stelara patent loss
BioPharma Dive
Wed, 10/16/24 - 05:19 pm
JNJ
Carvykti
Tremfya
Stelara
patents
J&J makes surgical robotic moves with Ottava FDA IDE application
Clinical Trials Arena
Wed, 10/16/24 - 12:31 pm
Medtech
JNJ
IDE
FDA
robotic surgery
Ottava

Pages